DN
David Nierengarten Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
41
Avg Return
Past Year
Past Year
15%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
78.7%
Neutral
21.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Healthcare
Technology
Consumer Discretionary
Residential Construction
Restaurants
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Instruments & Supplies
Technology
Solar
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $110 |
22%
upside
| 1 | +21% |
0
%
| 17 Oct ‘25 2 days ago |
|
|
|
Outperform
Maintained
| $70 |
102%
upside
| 2 | +53% |
0
%
| 15 Oct ‘25 4 days ago |
|
|
|
Outperform
Maintained
| $880 |
4%
upside
| 5 | +11% |
0
%
| 13 Oct ‘25 6 days ago |
|
|
|
Outperform
Maintained
| $44 |
14%
upside
| 2 | +40% |
0
%
| 13 Oct ‘25 6 days ago |
|
|
|
Outperform
Reiterated
| $6 |
76%
upside
| 5 | +9.8% |
0
%
| 13 Oct ‘25 6 days ago |
|
|
|
Outperform
Initiated
| $4 |
121%
upside
| 1 | +17% |
0
%
| 8 Sep ‘25 1 month ago |
|
|
|
Outperform
Reiterated
| $115 |
24%
upside
| 1 | +14% |
0
%
| 8 Sep ‘25 1 month ago |
|
|
|
Outperform
Reiterated
| $26 |
76%
upside
| 2 | +45% |
0
%
| 2 Sep ‘25 1 month ago |
|
|
|
Outperform
Reiterated
| $22 |
104%
upside
| 3 | -14% |
0
%
| 28 Aug ‘25 1 month ago |
|
|
|
Outperform
Initiated
| $25 |
124%
upside
| 1 | +4.7% |
0
%
| 18 Aug ‘25 2 months ago |
|
|
|
Neutral
Downgraded
| $7 |
13%
upside
| 1 | – |
–
| 13 Aug ‘25 2 months ago |
|
|
|
Neutral
Reiterated
| $8 |
72%
downside
| 1 | – |
–
| 26 Jun ‘25 3 months ago |
|
|
|
Outperform
Reiterated
| $11 |
145%
upside
| 3 | +0.54% |
0
%
| 23 Jun ‘25 3 months ago |
|
|
|
Neutral
Downgraded
| $129 |
0%
downside
| 3 | +8.8% |
0
%
| 2 Jun ‘25 4 months ago |
|
|
|
Neutral
Downgraded
| $12 | – | 1 | – |
–
| 28 May ‘25 4 months ago |
|
|
|
Neutral
Reiterated
| $10 |
60%
downside
| 2 | – |
–
| 19 May ‘25 5 months ago |
|
|
|
Neutral
Maintained
| $27 |
96%
upside
| 1 | – |
–
| 16 Apr ‘25 6 months ago |
|
|
|
Outperform
Reiterated
| $33 |
111%
upside
| 2 | +27% |
0
%
| 20 Mar ‘25 7 months ago |
|
|
|
Neutral
Downgraded
| $2 |
98%
upside
| 1 | – |
–
| 14 Mar ‘25 7 months ago |
|
|
|
Neutral
Reiterated
| $5 |
240%
upside
| 1 | – |
–
| 6 Mar ‘25 7 months ago |
|
|
|
Outperform
Reiterated
| $31 |
70%
upside
| 2 | +21% |
0
%
| 12 Feb ‘25 8 months ago |
|
|
|
Outperform
Reiterated
| $77 |
64%
upside
| 1 | -15% |
0
%
| 12 Feb ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $90 |
63%
upside
| 2 | +4.5% |
0
%
| 2 Dec ‘24 10 months ago |
|
|
|
Outperform
Maintained
| $47 |
68%
upside
| 1 | -6.6% |
0
%
| 25 Nov ‘24 10 months ago |
|
|
|
Outperform
Reiterated
| $6 |
30%
downside
| 1 | +894% |
0
%
| 18 Nov ‘24 11 months ago |
|